Brazil reaches deal for 10 million shots of Russian vaccine

An elderly man looks at the syringe before getting a jab of the Sinovac vaccine at a drive-thru site in Brasilia, Brazil, Thursday, March 11, 2021. (AP Photo/Eraldo Peres)

Brazil’s federal government said Friday it has reached a deal to purchase 10 million doses of the Russian-made Sputnik V vaccine against COVID-19, though the shot is yet to be approved by the South American nation’s health agency.

The Brazilian Health Ministry said on Twitter that the jabs will be imported by União Química, a company that has lobbied the government to purchase the vaccines, though its own experience is based on other medical products.

Brazil’s government expects to receive 400,000 shots in April, 2 million in May and another 7.6 million by June.

The ministry said it would also evaluate possible production of the Sputnik V vaccine by União Química plants in Brazil.

Brazil has already secured contracts for 200 million doses, half made by AstraZeneca and half by Chinese pharmaceutical company Sinovac.

Russia has sent millions of doses of Sputnik V around the world, even as it vaccinates its own population. Analysts say Russia seeks to bolster its image as a benevolent technological power at a time when COVID-19 jabs are in short supply because richer nations are stockpiling Western-made vaccines.

According to Our World in Data, an online research site that compares official statistics, only 5.5% of Brazilians have been vaccinated, and the country experiences a deadly second wave of COVID-19 with more than 2,000 registered deaths in each of the last two days.

More than 270,000 people died of the disease in Brazil, with authorities expecting grim weeks in March and April.

Brazil aims to buy 30 mn Sputnik V, Covaxin shots

© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Brazil reaches deal for 10 million shots of Russian vaccine (2021, March 12)
retrieved 12 March 2021

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Health News

Study finds cancer immunotherapy treatment can reverse HIV latency

Credit: Pixabay/CC0 Public Domain An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to ‘hide’ inside cells of people living with HIV on antiretroviral therapy, the major barrier to a cure for HIV. Pembrolizumab is a monoclonal antibody that reverses the ‘exhaustion’ of the […]

Read More
Health News

Gene therapy for the treatment of Huntington’s disease

Credit: Pixabay/CC0 Public Domain Gene therapy targeting the messenger RNA (mRNA) of the mutated huntingtin gene (HTT) can provide long-lasting therapeutic benefit in Huntington’s disease after a single administration. An adeno-associated virus (AAV) gene therapy containing a primary artificial microRNA (pri-amiRNA) targeting HTT mRNA is described in the peer-reviewed journal Human Gene Therapy. “The challenge […]

Read More
Health News

MRI of hand, foot may predict rheumatoid arthritis in undifferentiated arthritis

(HealthDay)—Magnetic resonance imaging (MRI) of the hand and foot may predict rheumatoid arthritis (RA) in patients presenting with undifferentiated arthritis (UA), according to a study published online Jan. 12 in Rheumatology. Nikolet K. den Hollander, M.D., Ph.D., from the Leiden University Medical Center in the Netherlands, and colleagues studied the predictive value of MRI for […]

Read More